Literature DB >> 19680812

Experimental validation of a theoretical model of cytokine capture using a hemoadsorption device.

Morgan V DiLeo1, James D Fisher, William J Federspiel.   

Abstract

Sepsis, a systemic inflammatory response in the presence of an infection, is characterized by overproduction of inflammatory mediators called cytokines. Removal of these cytokines using an extracorporeal hemoadsorption device is a potential therapy for sepsis. We are developing a cytokine adsorption device (CAD) filled with microporous polymer beads and have previously published a mathematical model which predicts the time course of cytokine removal by the device. The goal of this study was to show that the model can experimentally predict the rate of cytokine capture associated with key design and operational parameters of the CAD. We spiked IL-6, IL-10, and TNF into horse serum and perfused it through an appropriately scaled-down CAD and measured the change in concentration of the cytokines over time. These data were fit to the mathematical model to determine a single model parameter, Gamma( i ), which is only a function of the cytokine-polymer interaction and the cytokine effective diffusion coefficient in the porous matrix. We compared Gamma( i ) values, which by definition should not change between experiments. Our results indicate that the Gamma( i ) value for a specific cytokine was statistically independent of all other parameters in the model, including initial cytokine concentration, flow rate, serum reservoir volume, CAD size, and bead size. Our results also indicate that competitive adsorption of cytokines and other middle-molecular weight proteins, which is neglected in the model, does not affect the rate of removal of a given cytokine. The model of cytokine capture in the CAD developed in this study will be integrated with a systems model of sepsis to simulate the progression of sepsis in humans and to develop a therapeutic CAD design and intervention protocol that improves patient outcomes in sepsis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19680812      PMCID: PMC2771882          DOI: 10.1007/s10439-009-9780-4

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  21 in total

1.  Protein diffusion in charged polyacrylamide gels. Visualization and analysis.

Authors:  R K Lewus; G Carta
Journal:  J Chromatogr A       Date:  1999-12-31       Impact factor: 4.759

2.  Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia.

Authors:  John A Kellum; Mingchen Song; Ramesh Venkataraman
Journal:  Crit Care Med       Date:  2004-03       Impact factor: 7.598

3.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

4.  Effect of hindered diffusion on the adsorption of proteins in agarose gel using a pore model.

Authors:  Jan Gutenwik; Bernt Nilsson; Anders Axelsson
Journal:  J Chromatogr A       Date:  2004-09-10       Impact factor: 4.759

5.  Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids.

Authors:  I Berggård; A G Bearn
Journal:  J Biol Chem       Date:  1968-08-10       Impact factor: 5.157

6.  Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients.

Authors:  R Bellomo; P Tipping; N Boyce
Journal:  Crit Care Med       Date:  1993-04       Impact factor: 7.598

Review 7.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

8.  A simple mathematical model of cytokine capture using a hemoadsorption device.

Authors:  Morgan V DiLeo; John A Kellum; William J Federspiel
Journal:  Ann Biomed Eng       Date:  2008-10-24       Impact factor: 3.934

Review 9.  A new paradigm for the treatment of sepsis: is it time to consider combination therapy?

Authors:  Alan S Cross; Steven M Opal
Journal:  Ann Intern Med       Date:  2003-03-18       Impact factor: 25.391

10.  Effect of hemofiltration filter adsorption on circulating IL-6 levels in septic rats.

Authors:  John A Kellum; Michael K Dishart
Journal:  Crit Care       Date:  2002-06-19       Impact factor: 9.097

View more
  3 in total

1.  Modeling competitive cytokine adsorption dynamics within hemoadsorption beads used to treat sepsis.

Authors:  Jeremy D Kimmel; Emma M Harbert; Robert S Parker; William J Federspiel
Journal:  J Chromatogr A       Date:  2011-09-09       Impact factor: 4.759

2.  Selective improvement of tumor necrosis factor capture in a cytokine hemoadsorption device using immobilized anti-tumor necrosis factor.

Authors:  Morgan V DiLeo; James D Fisher; Brianne M Burton; William J Federspiel
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2011-01       Impact factor: 3.368

3.  IL-6 adsorption dynamics in hemoadsorption beads studied using confocal laser scanning microscopy.

Authors:  Jeremy D Kimmel; Gregory A Gibson; Simon C Watkins; John A Kellum; William J Federspiel
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2010-02       Impact factor: 3.368

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.